David Wheadon, M.D.
Board Member
Vaxart, Inc. (VXRT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Wheadon, M.D.
David Wheadon, M.D. is recorded as Board Member at Vaxart, Inc. (VXRT). Vaxart, Inc. reported in an 8-K filed June 13, 2024 that David Wheadon, M.D. was appointed Director, effective June 11, 2024.
“Stockholders elected the six nominees for directors to serve until the Company's 2025 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-11–present
-
Vaxart, Inc. (VXRT)
SEC 8-K
Current2021-04-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vaxart, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrei Floroiu CEO
- Michael Finney CEO
- Michael J. Finney CEO, Board Member
- Steven Lo CEO, Board Member
- Fuad Ahmad CFO
- Phillip E. Lee CFO, Chief Accounting Officer
- Edward Berg General Counsel
- Jeroen Grasman Chief Accounting Officer
- David Wheadon Board Member
- Elaine J. Heron Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.